Li, Jian <br/><br/>
[Irinotecan plus fuorouracil/leucovorin (FOLFIRI) as a second line chemotherapy for refractory or metastatic colorectal cancer].  [electronic resource] 

 -  Zhonghua zhong liu za zhi [Chinese journal of oncology]  Mar 2008 
 - 225-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0253-3766 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Camptothecin--administration & dosage<br/>Colonic Neoplasms--drug therapy<br/>Disease Progression<br/>Female<br/>Fluorouracil--adverse effects<br/>Follow-Up Studies<br/>Humans<br/>Irinotecan<br/>Leucovorin--adverse effects<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local<br/>Neutropenia--chemically induced<br/>Prospective Studies<br/>Rectal Neoplasms--drug therapy<br/>Remission Induction<br/>Survival Rate<br/>Vomiting--chemically induced<br/>Young Adult